2007
DOI: 10.1093/cvr/cvm014
|View full text |Cite
|
Sign up to set email alerts
|

Coronary flow regulation in mouse heart during hypercapnic acidosis: role of NO and its compensation during eNOS impairment

Abstract: NO-production and K ATP-channel activation together may fully account for the steady-state hypercapnic flow response in mouse heart. However, chronic deletion of eNOS does not result in a reduced hypercapnic flow response. Enhanced activation of K ATP-channels and potentially Kv-channels contributes to the compensatory mechanisms involved in the hypercapnic flow response when eNOS activity is absent.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
1

Year Published

2009
2009
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 30 publications
0
19
1
Order By: Relevance
“…The isolated, buffer-perfused mouse heart model has been developed to facilitate analysis of genetic manipulations 39 , cardioprotection during ischemia–reperfusion 38 , and coronary vascular function 40 . In the latter case, the perfused heart was used to characterize reactive hyperemia parameters of peak and excess flow following a brief periods of ischemia.…”
Section: Discussionmentioning
confidence: 99%
“…The isolated, buffer-perfused mouse heart model has been developed to facilitate analysis of genetic manipulations 39 , cardioprotection during ischemia–reperfusion 38 , and coronary vascular function 40 . In the latter case, the perfused heart was used to characterize reactive hyperemia parameters of peak and excess flow following a brief periods of ischemia.…”
Section: Discussionmentioning
confidence: 99%
“…Hypercapnic acidosis-induced increases in blood flow are inhibited by glibenclamide in mouse hearts (583) and in the cerebral circulation (401, 877). …”
Section: Katp Channelsmentioning
confidence: 99%
“…39 Potentially important compensatory roles for EDHF may make these factors even more dominant in coronary vascular regulation under conditions of impairment of NO bioavailability. [40][41][42][43][44][45][46] The importance and emerging knowledge concerning EDHF notwithstanding, the focus of the current review is on NO and coronary adaptations to hypertension, and the reader is referred to the cited works for further information on EDHF in the coronary vasculature.…”
Section: Introduction To Coronary Hemodynamics In Hypertensionmentioning
confidence: 99%